Vita Life Sciences Limited, Annual General Meeting, May 23, 2013., at 14:00 AUS Eastern Standard Time. Location: Level 1, St Kilda Road Towers. Agenda: To approve Financial Statements and remuneration Reports; to approve re-election of Directors; to approve share buy-back; to approve long term incentive plan: Amendment to terms of limited recourse loan to Managing Director to purchase ordinary shares; to approve long term incentive plan: Amendment of terms of limited recourse loan to Director of Subsidiary to purchase ordinary shares; and to approve other business.

Vita Life Sciences Limited reported earnings results for the year ended December 31, 2012. For the year, the company's revenue was $30.191 million compared with $24.267 million a year ago. EBIT was $2.865 million compared with $1.489 million a year ago. Profit before tax was $2.841 million compared with $1.403 million a year ago. Profit after tax was $2.316 million or 4.14 cents per share compared with $1.213 million or 2.12 cents per share a year ago. EBITDA was $2.87 million compared with $1.49 million a year ago. Operating cash flows were $1.38 million compared with $5.66 million a year ago. The company declared final dividend of 0.5 cent per share for the year ended December 31, 2012. Total dividend for the financial year was 1.0 cent per share. The dividend will be payable on March 28, 2013 to the shareholders of record on March 15, 2013. The ex-dividend date is March 8, 2013. Barring unforeseen circumstances, the company is targeting a 40% to 50% increase in EBIT in the fiscal year 2013.

Vita Life Sciences Limited announced that they will report fiscal year 2012 results on Feb 28, 2013